InsidersTradesSigma
Follow the ST景峰 share price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, ST景峰 has logged 4 insider filings. Market capitalisation: €10.8bn. The latest transaction was reported on 12 September 2023 (Purchase). Among the most active insiders: 叶湘武. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
ST景峰 es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XSHE. Se especializa en el desarrollo y la producción de productos farmacéuticos.